-
COVID-19 Vaccine and Heart Attack: Biocon Chief, Karnataka CM get into war of words
05 Jul 2025 15:22 GMT
… of words has erupted between Biocon founder Kiran Mazumdar-Shaw and … of the American College of Cardiology) have discussed myocarditis and cardiac …
-
'Seeking Clarity Is Not Misinformation': CM Siddaramaiah Responds To Biocon Chief On Covid Vaccine Row
04 Jul 2025 17:34 GMT
… , responding to objections raised by Biocon chief Kiran Mazumdar Shaw over … of the American College of Cardiology) have discussed myocarditis and cardiac …
-
COVID-19 vaccines linked to cardiac-related deaths? Siddaramaiah, Biocon founder Shaw spar on X
04 Jul 2025 11:49 GMT
… Karnataka Chief Minister Siddaramaiah and Biocon founder Kiran Mazumdar-Shaw. Charges … of the American College of Cardiology have discussed myocarditis and cardiac … ThePrint.
However, said the interventional cardiologist, in absence of evidence to …
-
Karnataka CM’s remarks on Covid vaccines “factually incorrect” says Biocon chief Kiran Mazumdar-Shaw, Siddaramaiah hits back
04 Jul 2025 08:04 GMT
Biocon founder Kiran Mazumdar-Shaw on … of the American College of Cardiology) have discussed myocarditis and cardiac …
-
'Covid vaccine takers have lower risk...': Cardiologist cites study to counter talk of heart attack spike post-jab
03 Jul 2025 08:17 GMT
A senior cardiologist from Delhi's GB … .
Dr Mohit Gupta, Professor of Cardiology at GB Pant Hospital, cited … : Dr Mohit Gupta, Professor of Cardiology, GB Pant Hospital says, … Hassan in the past month.
Biocon founder and Executive Chairperson Kiran …
-
Biocon Foundation marks 20 years of transforming lives with slew of healthcare initiatives
04 Mar 2025 10:21 GMT
… of Sri Jayadeva Institute of Cardiology Cardiovascular Sciences and Research who … Mazumdar-Shaw, chairperson, Biocon Group and Managing Trustee, Biocon Foundation, said, …
Dr Anupama Shetty, mission director, Biocon Foundation, said “This milestone is …
-
Biocon obtains approval for diabetes drug Liraglutide in UK
28 Mar 2024 18:16 GMT
… , commented, “The partnership with Biocon on Liraglutide reaffirms the strong … in key therapeutical areas like Cardiology & Circulation, Diabetes, Oncology, …
Read also: Eris Lifesciences acquires Biocon Biologics India branded formulation business …
-
Eris Lifesciences acquires Biocon Biologics India branded formulation business for Rs 1242 crore
15 Mar 2024 10:11 GMT
… has announced the acquisition of Biocon Biologics' India branded … Swiss Parenterals business. The Biocon product range can be … long-term collaboration with Biocon which is an organisation … (#5 among Diabetologists and Cardiologists) and strong cash.
-
Biocon Limited enters into a commercialization agreement with Zentiva in Europe
24 Nov 2022 06:13 GMT
… therapeutic areas, including diabetes, cardiology, respiratory and oncology. With … Officer and Managing Director, Biocon Ltd, said, " … Head - Generic Formulations, Biocon Ltd, added. " … This partnership will help Biocon to achieve its strategic …
-
Biocon appoints Susheel Umesh as CCO, Emerging Markets
02 Mar 2021 09:30 GMT
… Executive Officer.
With this appointment, Biocon Biologics will move its commercial … .”
Dr Arun Chandavarkar, Managing Director, Biocon Biologics said, “We are extremely … therapy areas, including diabetes, oncology, cardiology and transplantation, and has a …
About
© 1995-2025